The Management of Inflammatory Bowel Disease (IBD)
Surgical management of Ulcerative Colitis and Crohn’s Disease in 2026 focuses on "bowel conservation." For Crohn's patients, the use of Strictureplasty—a technique where narrowed segments of the bowel are widened rather than removed—has become the gold standard. This prevents "Short Bowel Syndrome," a condition where patients lose so much intestine they can no longer absorb nutrients.
For Ulcerative Colitis, the J-Pouch (Ileal Pouch-Anal Anastomosis) procedure is now performed almost exclusively via robotic-assisted platforms. The precision of the robot allows for a more functional internal reservoir, providing patients with better long-term bowel control. Surgeons in 2026 also work closely with "IBD Pharmacologists" to time surgeries around the latest biologic and small-molecule therapies, minimizing the risk of wound-healing complications.